MASP-2-TARGETTING ANTIBODIES AND USES THEREOF - INMAGENE BIOPHARMACEUTICALS HANGZHOU CO LTD

Title:

MASP-2-TARGETTING ANTIBODIES AND USES THEREOF

Document Type and Number:

WIPO Patent Application WO/2023/174039

Kind Code:

A1

Abstract:

Disclosed herein are anti-MASP-2 antibodies and antigen-binding fragments, polynucleotides encoding the antibodies and antigen-binding fragments, and pharmaceutical compositions comprising the antibodies and antigen-binding fragments. Uses of the anti-MASP-2 antibodies and antigen-binding fragments described herein in treatment of conditions and disorders associated completement activation are also disclosed.

More Like This:

JP2004147542	GLYCOSYLTRANSFERASE, NUCLEIC ACID ENCODING THE SAME AND METHOD FOR DETECTING CANCER TISSUE USING THE SAME NUCLEIC ACID
JP3717958	TRUNCATED HUMAN CHOLESTEROL 7ALPHA-HYDROXYLASE METHOD OF PRODUCTION AND USE OF THE SAME
JP2004524007	Antibodies to human cytochrome P4502D6

Inventors:

GUO CHONGTIAN (CN)
LEI RUN (CN)
FAN PENGCHENG (CN)
FAN LIHUA (CN)
XU ZHIHAO (CN)
SUN QIANG (CN)
WANG JONATHAN JIAN (CN)

Application Number:

PCT/CN2023/078260

Publication Date:

September 21, 2023

Filing Date:

February 24, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

INMAGENE BIOPHARMACEUTICALS HANGZHOU CO LTD (CN)
INMAGENE PTE LTD (SG)

International Classes:

C07K16/40; A61K39/395; A61P1/00; A61P3/00; A61P5/00; A61P7/00; A61P9/00; A61P11/00; A61P13/00; A61P15/00; A61P17/00; A61P19/00; A61P21/00; A61P25/00; C12N15/13; C12N15/63

Domestic Patent References:

WO2021178902A1

2021-09-10

Foreign References:

CN102781471A	2012-11-14
CN1449440A	2003-10-15
CN103687620A	2014-03-26
CN1798769A	2006-07-05

Attorney, Agent or Firm:

SHANGHAI BESHINING LAW OFFICE (CN)

Download PDF:

View/Download PDF PDF Help

Previous Patent: DATA TRANSMISSION METHOD AND RELATED DEVICE

Next Patent: PICTURE PROCESSING METHOD AND RELATED DEVICE